Home › Ovarian Epithelial Carcinoma › Wisconsin
Ovarian Epithelial Carcinoma clinical trials in Wisconsin
3 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in Wisconsin.
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Froedtert and The Medical College of Wisconsin, Milwaukee
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT06915025Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- University of Wisconsin, Madison
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 28, 2026 · NCT06819007ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- ThedaCare Regional Cancer Center, Appleton
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.